VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 166 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $719,000 | -40.4% | 28,214 | -39.9% | 0.05% | -21.7% |
| Q1 2022 | $1,207,000 | -38.5% | 46,914 | 0.0% | 0.07% | -31.0% |
| Q4 2021 | $1,964,000 | -4.2% | 46,914 | -0.4% | 0.10% | -10.7% |
| Q3 2021 | $2,050,000 | -9.2% | 47,095 | -1.3% | 0.11% | -9.7% |
| Q2 2021 | $2,257,000 | -7.8% | 47,739 | 0.0% | 0.12% | -16.2% |
| Q1 2021 | $2,448,000 | +86.7% | 47,739 | -2.5% | 0.15% | +92.2% |
| Q4 2020 | $1,311,000 | -22.0% | 48,973 | 0.0% | 0.08% | -32.5% |
| Q3 2020 | $1,681,000 | – | 48,973 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
| SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
| Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
| SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
| ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
| Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
| DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
| Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |